Why the study?
Does the use of a centrifugal pump reduce blood product transfusion and chest tube drainage in patients undergoing routine open heart surgery?
Does the use of a centrifugal pump reduce blood product transfusion and chest tube drainage in patients undergoing routine open heart surgery?
The use of a centrifugal pump during open heart surgery decreases chest tube drainage and transfusion requirements, leading to a shorter hospital stay compared to a roller pump.
Answers are grounded in this paper and cite their sources.
Centrifugal pumps merit first-line use in open heart surgery; confirms reduced transfusions and shorter stays versus roller pumps.
A prospective randomized study was done including 1,000 patients undergoing routine open heart surgery. Patients were randomly assigned to either a roller pump or a BioMedicus centrifugal pump with identical extracorporeal circuits. There were no significant differences between study groups. Actual blood products transfused and predicted transfusion requirements (using Cardiac RiskMaster) were examined as was chest tube drainage (CTD). The predicted transfusion requirement was 885 of 1,000 patients. Transfusions were required by 472 of 1,000. Risk factors as significant predictors of increased CTD and use of blood products were emergency surgery status, increased cross-clamp time, and higher predicted risk of mortality. The only significant predictor of decreased CTD was the use of a centrifugal pump. Predictors of increased length of stay were myocardial infarction, preoperative urea, age, and massive transfusion. Data provide evidence that use of the centrifugal pump improves patient outcomes by decreasing CTD and decreasing the requirements for transfusion, which results in a shorter hospital stay.
No takes yet. Share an insight, caveat, or question.
Klein et al. (2001) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: